Skye Bioscience, Inc. (NASDAQ:SKYE) has 44 institutional investors that have filed 13F reports for the period ending June 2026.
| # | Institution | CIK | Shares Held | % of Outstanding | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|---|---|
| 1 | 5AM Venture Management, LLC | 0001799883 | 1,210,220 | 24.39% | 0 | 0.00% | $6.71Mn |
| 2 | Versant Venture Management, LLC | 0001560009 | 250,963 | 5.06% | 0 | 0.00% | $1.39Mn |
| 3 | BAKER BROS. ADVISORS LP | 0001263508 | 196,905 | 3.97% | 0 | 0.00% | $1.09Mn |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0002100119 | 95,485 | 1.92% | ▼72 | -0.08% | $529.37K |
| 5 | SPHERA FUNDS MANAGEMENT LTD. | 0001496201 | 84,866 | 1.71% | 0 | 0.00% | $470.70K |
| 6 | PLATINUM INVESTMENT MANAGEMENT LTD | 0001256071 | 29,137 | 0.59% | 0 | 0.00% | $161.61K |
| 7 | BlackRock, Inc. | 0002012383 | 29,109 | 0.59% | ▼6,657 | -18.61% | $161.45K |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0001214717 | 27,257 | 0.55% | ▼7,400 | -21.35% | $151.23K |
| 9 | MILLENNIUM MANAGEMENT LLC | 0001273087 | 24,816 | 0.50% | ▼7,460 | -23.11% | $137.64K |
| 10 | VANGUARD FIDUCIARY TRUST CO | 0000933478 | 13,029 | 0.26% | 0 | 0.00% | $72.23K |
| 11 | State Street Corp | 0000093751 | 9,229 | 0.19% | ▼187 | -1.99% | $51.19K |
| 12 | UBS Group AG | 0001610520 | 9,225 | 0.19% | ▲3,505 | +61.27% | $51.14K |
| 13 | Northern Trust Corp | 0000073124 | 7,041 | 0.14% | ▲4,523 | +179.65% | $39.05K |
| 14 | Qube Research & Technologies Ltd | 0001729829 | 5,385 | 0.11% | ▲5,385 | 0.00% | $29.87K |
| 15 | SIMPLEX TRADING, LLC | 0001488542 | 3,372 | 0.07% | ▲3,372 | 0.00% | $18.70K |
| 16 | XTX Topco Ltd | 0001828301 | 2,624 | 0.05% | ▼2,491 | -48.70% | $14.55K |
| 17 | Engineers Gate Manager LP | 0001620220 | 2,524 | 0.05% | 0 | 0.00% | $14.00K |
| 18 | GROUP ONE TRADING LLC | 0000932540 | 574 | 0.01% | ▼327 | -36.31% | $3.18K |
| 19 | Vanguard Global Advisers, LLC | 0001811242 | 570 | 0.01% | 0 | 0.00% | $3.16K |
| 20 | MERCER GLOBAL ADVISORS INC /ADV | 0000853758 | 383 | 0.01% | ▲383 | 0.00% | $2.13K |